Back to companies

KYORIN Pharmaceutical Co Ltd: Deals

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on KYORIN Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Register your interest

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
06 Mar 2023 Sumitomo Pharma Enters into Licensing Agreement with Kyorin Pharma Licensing Agreement Sumitomo Pharma Co Ltd
Kyorin Pharmaceutical Co Ltd  

09 Nov 2022 Kyorin Pharma Enters into Agreement with Susmed Partnership -
SUSMED Inc  

Kyorin Pharmaceutical Co Ltd  

17 Jun 2022 Kyorin Pharma Enters into Licensing Agreement with CellGenTech Licensing Agreement
Kyorin Pharmaceutical Co Ltd  

CellGenTech Inc  

06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Register your interest
Get in touch about GlobalData Explorer

Contact the team or request a demo to find out how our data can drive your business forward

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer